HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peng Xie Selected Research

Pindolol (LB 46)

5/2015Is pindolol augmentation effective in depressed patients resistant to selective serotonin reuptake inhibitors? A systematic review and meta-analysis.
4/2015Comparative efficacy, acceptability, and tolerability of augmentation agents in treatment-resistant depression: systematic review and network meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peng Xie Research Topics

Disease

49Neoplasms (Cancer)
12/2022 - 05/2008
35Major Depressive Disorder (Major Depressive Disorders)
01/2022 - 04/2012
24Infections
01/2022 - 08/2006
19Inflammation (Inflammations)
06/2022 - 10/2014
15Neoplasm Metastasis (Metastasis)
01/2022 - 03/2010
12Schizophrenia (Dementia Praecox)
01/2022 - 07/2014
12Glioma (Gliomas)
01/2020 - 01/2014
11Stroke (Strokes)
11/2022 - 03/2015
9Depressive Disorder (Melancholia)
01/2022 - 06/2006
9Bipolar Disorder (Manic Depressive Psychosis)
02/2021 - 01/2014
9Treatment-Resistant Depressive Disorder
01/2020 - 12/2013
8Reperfusion Injury
12/2022 - 01/2016
8Hypoxia (Hypoxemia)
12/2022 - 01/2016
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 02/2012
7Body Weight (Weight, Body)
08/2022 - 04/2013
7Ischemic Stroke
02/2020 - 07/2008
7Carcinoma (Carcinomatosis)
11/2019 - 12/2010
7Nasopharyngeal Carcinoma
08/2019 - 06/2010
6Lung Neoplasms (Lung Cancer)
09/2021 - 11/2015
5Ischemia
01/2022 - 06/2010
5Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 10/2020
5Glioblastoma (Glioblastoma Multiforme)
08/2021 - 11/2015
5Brain Ischemia (Cerebral Ischemia)
12/2020 - 03/2009
5Virus Diseases (Viral Diseases)
06/2019 - 01/2012
4Dysbiosis
10/2022 - 10/2020
4Hemorrhage
09/2022 - 06/2010
4Metabolic Syndrome (Dysmetabolic Syndrome X)
08/2022 - 03/2018
4Hepatocellular Carcinoma (Hepatoma)
06/2022 - 01/2017
4Pain (Aches)
03/2022 - 01/2020
4Cerebral Hemorrhage
03/2022 - 11/2012
4Carcinogenesis
01/2022 - 01/2017
4Myocardial Ischemia (Ischemic Heart Diseases)
01/2022 - 01/2016
4Congenital Abnormalities (Deformity)
12/2021 - 07/2015
4Esophagitis
05/2021 - 01/2014
4Mental Disorders (Mental Disorder)
01/2021 - 01/2015
4Melanoma (Melanoma, Malignant)
01/2021 - 06/2009
4Pathologic Constriction (Stenosis)
07/2020 - 12/2014
4Chronic Renal Insufficiency
11/2019 - 01/2013
3Heart Failure
12/2022 - 01/2021
3Hyperglycemia
03/2022 - 01/2020
3Dyslipidemias (Dyslipidemia)
01/2022 - 02/2021
3Myocardial Infarction
01/2022 - 01/2017
3Anhedonia
01/2022 - 05/2016
3Weight Gain
01/2022 - 02/2021
3Breast Neoplasms (Breast Cancer)
06/2021 - 05/2015
3Hypertension (High Blood Pressure)
01/2020 - 04/2010
3Esophageal Neoplasms (Esophageal Cancer)
01/2020 - 01/2012
3Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2020 - 01/2017
3Osteoarthritis
01/2020 - 01/2019
3Alzheimer Disease (Alzheimer's Disease)
07/2019 - 03/2013

Drug/Important Bio-Agent (IBA)

31Proteins (Proteins, Gene)FDA Link
01/2022 - 09/2014
29Biomarkers (Surrogate Marker)IBA
06/2022 - 01/2013
16Antidepressive Agents (Antidepressants)IBA
01/2021 - 01/2013
15MicroRNAs (MicroRNA)IBA
03/2022 - 12/2010
11LipidsIBA
10/2022 - 05/2008
10Pharmaceutical PreparationsIBA
01/2022 - 07/2015
10Messenger RNA (mRNA)IBA
01/2021 - 06/2014
9RNA (Ribonucleic Acid)IBA
03/2022 - 08/2014
9Biological ProductsIBA
01/2022 - 05/2015
8Phosphotransferases (Kinase)IBA
01/2022 - 05/2008
7Antipsychotic Agents (Antipsychotics)IBA
01/2022 - 01/2013
7Long Noncoding RNAIBA
01/2021 - 06/2016
6Tissue Plasminogen Activator (Alteplase)FDA Link
11/2022 - 03/2009
6Interleukin-6 (Interleukin 6)IBA
12/2020 - 09/2011
6Sevoflurane (Ultane)FDA LinkGeneric
01/2020 - 01/2016
6CateninsIBA
01/2020 - 08/2012
5Amino AcidsFDA Link
10/2022 - 01/2012
5Cisplatin (Platino)FDA LinkGeneric
06/2022 - 10/2019
5Sucrose (Saccharose)IBA
01/2022 - 05/2016
5PlatinumIBA
12/2021 - 10/2017
5Neuroprotective AgentsIBA
01/2019 - 03/2009
4Peroxisome Proliferator-Activated Receptors (PPAR)IBA
08/2022 - 04/2010
4CytokinesIBA
06/2022 - 01/2020
4Glucose (Dextrose)FDA LinkGeneric
03/2022 - 07/2015
4Olanzapine (Zyprexa)FDA Link
01/2022 - 04/2015
4Antiviral Agents (Antivirals)IBA
01/2022 - 12/2014
4Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
06/2015 - 06/2010
4AntibodiesIBA
03/2015 - 09/2009
3Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
12/2022 - 01/2021
3Therapeutic UsesIBA
06/2022 - 01/2018
3Type A Botulinum Toxins (Botox)FDA Link
02/2022 - 01/2019
3Neurotransmitter Agents (Neurotransmitter)IBA
01/2022 - 01/2018
3Glutamic Acid (Glutamate)FDA Link
01/2022 - 06/2012
3ErbB Receptors (EGF Receptor)IBA
12/2021 - 01/2016
3Lysine (L-Lysine)FDA Link
01/2021 - 09/2014
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2020 - 11/2016
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2020 - 01/2017
3Interleukin-10 (Interleukin 10)IBA
01/2020 - 11/2015
3Adenosine Triphosphate (ATP)IBA
01/2020 - 06/2012
3Circular RNAIBA
01/2020 - 01/2017
3SolutionsIBA
01/2020 - 01/2014
3AcidsIBA
11/2019 - 01/2013
3Analgesics (Analgesic Drugs)IBA
10/2019 - 03/2010
3Matrix Metalloproteinases (MMPs)IBA
08/2019 - 02/2016

Therapy/Procedure

37Therapeutics
12/2022 - 03/2009
13Drug Therapy (Chemotherapy)
01/2022 - 01/2014
13Radiotherapy
01/2022 - 03/2009
6Chemoradiotherapy
01/2020 - 01/2014
5Aftercare (After-Treatment)
11/2022 - 07/2011
3Conservative Treatment
01/2021 - 11/2015